Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CEA and ABO(H) in upper urinary tract transitional tumors.

P Dalla Palma, A Parenti, A Poletti

    Applied Pathology
    |January 1, 1984
    PubMed
    Summary

    Carcinoembryonic antigen (CEA) is not a reliable tumor marker for transitional cell carcinomas. However, CEA may correlate with tumor grade and vascular invasion, while ABO(H) isoantigens show no prognostic value.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.

    Physical review letters·2026
    Same author

    Diverse Properties of Electron Forbush Decreases Revealed by the Dark Matter Particle Explorer.

    Physical review letters·2026
    Same author

    <b></b> : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors' profiles.

    Computational and structural biotechnology journal·2022
    Same author

    Insights on Human Small Heat Shock Proteins and Their Alterations in Diseases.

    Frontiers in molecular biosciences·2022
    Same author

    Demographic, clinical, and service-use characteristics related to the clinician's recommendation to transition from child to adult mental health services.

    Social psychiatry and psychiatric epidemiology·2022
    Same author

    Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma.

    Blood cancer journal·2022

    Area of Science:

    • Urothelial Carcinomas
    • Tumor Markers
    • Immunohistochemistry

    Background:

    • Transitional cell carcinomas of the upper urinary tract present diagnostic challenges.
    • Prognostic markers are crucial for predicting the clinical course of these tumors.

    Purpose of the Study:

    • To investigate the expression and prognostic significance of carcinoembryonic antigen (CEA) and ABO(H) isoantigens in pelvic and ureteral transitional cell carcinomas.
    • To evaluate the utility of these markers in conjunction with histological and immunohistochemical techniques for predicting tumor behavior.

    Main Methods:

    • Analysis of 40 cases of pelvic and ureteral transitional cell carcinomas.
    • Utilized histological techniques and immunohistochemical studies to assess CEA and ABO(H) isoantigen expression.

    Main Results:

    • CEA was not consistently expressed across all tumors, limiting its utility as a universal tumor marker, though it was detected in cystic pyelitis.
    • CEA expression showed a potential association with prognostic factors like tumor grading and vascular invasion.
    • ABO(H) isoantigen expression did not correlate with prognosis, with many advanced and high-grade tumors showing positivity.
    • Combined histological and immunohistochemical approaches were less effective for predicting upper tract tumors compared to bladder tumors.

    Conclusions:

    • CEA is not a definitive tumor marker for transitional cell carcinomas but may offer prognostic insights.
    • ABO(H) isoantigens lack prognostic value in these tumors.
    • The predictive utility of immunohistochemical markers for upper urinary tract transitional tumors may differ from that observed in bladder tumors.

    Related Experiment Videos